Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
European Pharmaceutical Review is Scopus-indexed (Q4, CiteScore 0.2). Published by Russell Publishing.
Checked against the index lists dated .
ISSN 1360-8606Verify ISSN ↗
Publisher: Russell Publishing
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biotechnology | 315 / 325 | 3rd | Q4 |
| Pharmacology, Toxicology and Pharmaceutics (all) | 78 / 79 | 1st | Q4 |
| Biophysics | 153 / 155 | 1st | Q4 |
| Molecular Medicine | 178 / 179 | 0th | Q4 |
| Biochemistry | 446 / 448 | 0th | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2023–2024 (also 2009–2019), best quartile Q4, CiteScore 0.2.
European Pharmaceutical Review is Q4 in Biotechnology (rank 315 of 325), Q4 in Pharmacology, Toxicology and Pharmaceutics (all) (rank 78 of 79) and Q4 in Biophysics (rank 153 of 155), by CiteScore 2025. It is ranked in 5 subject areas in all.
European Pharmaceutical Review is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.2, quartile Q4, 3rd percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.119, quartile Q4, with an H-index of 10.
European Pharmaceutical Review is published by Russell Publishing. Its ISSN is 1360-8606.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
European Pharmaceutical Review has an h-index of 10 and a 2-year mean of 0 citations per paper (OpenAlex). Its Scopus CiteScore is 0.2, quartile Q4. On 2-year citations it ranks #289 of 309 Scopus journals in Biotechnology.
European Pharmaceutical Review published 47 papers in 2021; its busiest recent year was 2020 with 118. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.